Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES)
Condition: Extrathoracic Sarcoidosis Interventions: Drug: Infliximab; Drug: Placebo Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Remicade | Sarcoidosis